Skip to main content

2015 | OriginalPaper | Buchkapitel

Identification of Osteosarcoma-Related Genes Based on Bioinformatics Methods

verfasst von : Ze-Bing Si, Ji-Gong Wu

Erschienen in: Intelligent Computing Theories and Methodologies

Verlag: Springer International Publishing

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

Osteosarcoma is one of the malignant cancers. Improving diagnosis and treatment of this disease is urgent. Microarray data have revealed abnormal expression of several genes implicated in osteosarcoma. From the mRNA data, differentially expressed (DE) genes were selected by Wilcox test. Using Endeavour online service, 200 DE genes were selected as osteosarcoma related genes. Combing the module extraction algorithm, we identified 90 osteosarcoma candidate genes. Nine (DCC, FGFR, Fzd1, NFKBIA, CCNE1, CASP3, APC, and LRP6) out of the 90 candidate genes have great potential roles in osteosarcoma.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Literatur
1.
Zurück zum Zitat Miao, J., Wu, S., Peng, Z., Tania, M., Zhang, C.: MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects. Tumor Biol. 34, 2093–2098 (2013)CrossRef Miao, J., Wu, S., Peng, Z., Tania, M., Zhang, C.: MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects. Tumor Biol. 34, 2093–2098 (2013)CrossRef
2.
Zurück zum Zitat Hameedand, M., Dorfman, H.: Primary malignant bone tumors—recent developments. Semin. Diagn. Pathol. 28, 86–101 (2011)CrossRef Hameedand, M., Dorfman, H.: Primary malignant bone tumors—recent developments. Semin. Diagn. Pathol. 28, 86–101 (2011)CrossRef
3.
Zurück zum Zitat Zou, C., Shen, J., Tang, Q., Yang, Z., Yin, J., Li, Z., Xie, X., Huang, G., Lev, D., Wang, J.: Cancer-testis antigens expressed in osteosarcoma identified by gene microarray correlate with a poor patient prognosis. Cancer 118, 1845–1855 (2012)CrossRef Zou, C., Shen, J., Tang, Q., Yang, Z., Yin, J., Li, Z., Xie, X., Huang, G., Lev, D., Wang, J.: Cancer-testis antigens expressed in osteosarcoma identified by gene microarray correlate with a poor patient prognosis. Cancer 118, 1845–1855 (2012)CrossRef
4.
Zurück zum Zitat Kanehisaand, M., Goto, S.: KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27–30 (2000)CrossRef Kanehisaand, M., Goto, S.: KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27–30 (2000)CrossRef
5.
Zurück zum Zitat Tranchevent, L.-C., Barriot, R., Yu, S., Van Vooren, S., Van Loo, P., Coessens, B., De Moor, B., Aerts, S., Moreau, Y.: ENDEAVOUR update: a web resource for gene prioritization in multiple species. Nucleic Acids Res. 36, W377–W384 (2008)CrossRef Tranchevent, L.-C., Barriot, R., Yu, S., Van Vooren, S., Van Loo, P., Coessens, B., De Moor, B., Aerts, S., Moreau, Y.: ENDEAVOUR update: a web resource for gene prioritization in multiple species. Nucleic Acids Res. 36, W377–W384 (2008)CrossRef
6.
Zurück zum Zitat Cerami, E., Demir, E., Schultz, N., Taylor, B.S., Sander, C.: Automated network analysis identifies core pathways in glioblastoma. PLoS ONE 5, e8918 (2010)CrossRef Cerami, E., Demir, E., Schultz, N., Taylor, B.S., Sander, C.: Automated network analysis identifies core pathways in glioblastoma. PLoS ONE 5, e8918 (2010)CrossRef
7.
Zurück zum Zitat Alvord, G., Roayaei, J., Stephens, R., Baseler, M.W., Lane, H.C., Lempicki, R.A.: The DAVID gene functional classification tool: a novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol. 8, 183 (2007)CrossRef Alvord, G., Roayaei, J., Stephens, R., Baseler, M.W., Lane, H.C., Lempicki, R.A.: The DAVID gene functional classification tool: a novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol. 8, 183 (2007)CrossRef
8.
Zurück zum Zitat Benjamini, Y., Hochberg, Y.: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. Roy. Stat. Soc. Ser. B (Methodological) 57, 289–300 (1995)MathSciNet Benjamini, Y., Hochberg, Y.: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. Roy. Stat. Soc. Ser. B (Methodological) 57, 289–300 (1995)MathSciNet
9.
Zurück zum Zitat Horstmannand, M., PÃ, M.: Frequent reduction or loss of DCC gene expression in human osteosarcoma. Br. J. Cancer 75, 1309 (1997)CrossRef Horstmannand, M., PÃ, M.: Frequent reduction or loss of DCC gene expression in human osteosarcoma. Br. J. Cancer 75, 1309 (1997)CrossRef
10.
Zurück zum Zitat Turner, N., Pearson, A., Sharpe, R., Lambros, M., Geyer, F., Lopez-Garcia, M.A., Natrajan, R., Marchio, C., Iorns, E., Mackay, A.: FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer. Cancer Res. 70, 2085–2094 (2010)CrossRef Turner, N., Pearson, A., Sharpe, R., Lambros, M., Geyer, F., Lopez-Garcia, M.A., Natrajan, R., Marchio, C., Iorns, E., Mackay, A.: FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer. Cancer Res. 70, 2085–2094 (2010)CrossRef
11.
Zurück zum Zitat Fernanda Amary, M., Ye, H., Berisha, F., Khatri, B., Forbes, G., Lehovsky, K., Frezza, A.M., Behjati, S., Tarpey, P., Pillay, N.: Fibroblastic growth factor receptor 1 amplification in osteosarcoma is associated with poor response to neo‐adjuvant chemotherapy. Cancer Med. 3, 980–987 (2014)CrossRef Fernanda Amary, M., Ye, H., Berisha, F., Khatri, B., Forbes, G., Lehovsky, K., Frezza, A.M., Behjati, S., Tarpey, P., Pillay, N.: Fibroblastic growth factor receptor 1 amplification in osteosarcoma is associated with poor response to neo‐adjuvant chemotherapy. Cancer Med. 3, 980–987 (2014)CrossRef
12.
Zurück zum Zitat Liu, H., Chen, Y., Zhou, F., Jie, L., Pu, L., Ju, J., Li, F., Dai, Z., Wang, X., Zhou, S.: Sox9 regulates hyperexpression of Wnt1 and Fzd1 in human osteosarcoma tissues and cells. Int. J. Clin. Exp. Pathol. 7, 4795 (2014) Liu, H., Chen, Y., Zhou, F., Jie, L., Pu, L., Ju, J., Li, F., Dai, Z., Wang, X., Zhou, S.: Sox9 regulates hyperexpression of Wnt1 and Fzd1 in human osteosarcoma tissues and cells. Int. J. Clin. Exp. Pathol. 7, 4795 (2014)
13.
Zurück zum Zitat Al-Romaih, K., Somers, G.R., Bayani, J., Hughes, S., Prasad, M., Cutz, J.-C., Xue, H., Zielenska, M., Wang, Y., Squire, J.A.: Modulation by decitabine of gene expression and growth of osteosarcoma U2OS cells in vitro and in xenografts: identification of apoptotic genes as targets for demethylation. Cancer Cell Int. 7, 14 (2007)CrossRef Al-Romaih, K., Somers, G.R., Bayani, J., Hughes, S., Prasad, M., Cutz, J.-C., Xue, H., Zielenska, M., Wang, Y., Squire, J.A.: Modulation by decitabine of gene expression and growth of osteosarcoma U2OS cells in vitro and in xenografts: identification of apoptotic genes as targets for demethylation. Cancer Cell Int. 7, 14 (2007)CrossRef
14.
Zurück zum Zitat Sollazzo, V., Galasso, M., Volinia, S., Carinci, F.: Prion proteins (PRNP and PRND) are over-expressed in osteosarcoma. J. Orthop. Res. 30, 1004–1012 (2012)CrossRef Sollazzo, V., Galasso, M., Volinia, S., Carinci, F.: Prion proteins (PRNP and PRND) are over-expressed in osteosarcoma. J. Orthop. Res. 30, 1004–1012 (2012)CrossRef
15.
Zurück zum Zitat Calò, V., Migliavacca, M., Bazan, V., Macaluso, M., Buscemi, M., Gebbia, N., Russo, A.: STAT proteins: from normal control of cellular events to tumorigenesis. J. Cell. Physiol. 197, 157–168 (2003)CrossRef Calò, V., Migliavacca, M., Bazan, V., Macaluso, M., Buscemi, M., Gebbia, N., Russo, A.: STAT proteins: from normal control of cellular events to tumorigenesis. J. Cell. Physiol. 197, 157–168 (2003)CrossRef
16.
Zurück zum Zitat Ryu, K., Choy, E., Yang, C., Susa, M., Hornicek, F.J., Mankin, H., Duan, Z.: Activation of signal transducer and activator of transcription 3 (Stat3) pathway in osteosarcoma cells and overexpression of phosphorylated-Stat3 correlates with poor prognosis. J. Orthop. Res. 28, 971–978 (2010) Ryu, K., Choy, E., Yang, C., Susa, M., Hornicek, F.J., Mankin, H., Duan, Z.: Activation of signal transducer and activator of transcription 3 (Stat3) pathway in osteosarcoma cells and overexpression of phosphorylated-Stat3 correlates with poor prognosis. J. Orthop. Res. 28, 971–978 (2010)
17.
Zurück zum Zitat Nakayama, N., Nakayama, K., Shamima, Y., Ishikawa, M., Katagiri, A., Iida, K., Miyazaki, K.: Gene amplification CCNE1 is related to poor survival and potential therapeutic target in ovarian cancer. Cancer 116, 2621–2634 (2010)CrossRef Nakayama, N., Nakayama, K., Shamima, Y., Ishikawa, M., Katagiri, A., Iida, K., Miyazaki, K.: Gene amplification CCNE1 is related to poor survival and potential therapeutic target in ovarian cancer. Cancer 116, 2621–2634 (2010)CrossRef
18.
Zurück zum Zitat Luo, Q., Li, X., Li, J., Kong, X., Zhang, J., Chen, L., Huang, Y., Fang, L.: MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer. Int. J. Oncol. 43, 1212–1218 (2013) Luo, Q., Li, X., Li, J., Kong, X., Zhang, J., Chen, L., Huang, Y., Fang, L.: MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer. Int. J. Oncol. 43, 1212–1218 (2013)
19.
Zurück zum Zitat Lockwood, W.W., Stack, D., Morris, T., Grehan, D., O’Keane, C., Stewart, G.L., Cumiskey, J., Lam, W.L., Squire, J.A., Thomas, D.M.: Cyclin E1 is amplified and overexpressed in osteosarcoma. J. Mol. Diagn. 13, 289–296 (2011)CrossRef Lockwood, W.W., Stack, D., Morris, T., Grehan, D., O’Keane, C., Stewart, G.L., Cumiskey, J., Lam, W.L., Squire, J.A., Thomas, D.M.: Cyclin E1 is amplified and overexpressed in osteosarcoma. J. Mol. Diagn. 13, 289–296 (2011)CrossRef
20.
Zurück zum Zitat Zhang, Z., Yu, X., Guo, Y., Song, W., Yu, D., Zhang, X.: Genetic variant in CASP3 affects promoter activity and risk of esophageal squamous cell carcinoma. Cancer Sci. 103, 555–560 (2012)CrossRef Zhang, Z., Yu, X., Guo, Y., Song, W., Yu, D., Zhang, X.: Genetic variant in CASP3 affects promoter activity and risk of esophageal squamous cell carcinoma. Cancer Sci. 103, 555–560 (2012)CrossRef
21.
Zurück zum Zitat Entz-Werle, N., Lavaux, T., Metzger, N., Stoetzel, C., Lasthaus, C., Marec, P., Kalita, C., Brugieres, L., Pacquement, H., Schmitt, C.: Involvement of MET/TWIST/APC combination or the potential role of ossification factors in pediatric high-grade osteosarcoma oncogenesis. Neoplasia 9, 678–688 (2007)CrossRef Entz-Werle, N., Lavaux, T., Metzger, N., Stoetzel, C., Lasthaus, C., Marec, P., Kalita, C., Brugieres, L., Pacquement, H., Schmitt, C.: Involvement of MET/TWIST/APC combination or the potential role of ossification factors in pediatric high-grade osteosarcoma oncogenesis. Neoplasia 9, 678–688 (2007)CrossRef
22.
Zurück zum Zitat Guimarães, A.P.G., Rocha, R.M., da Cunha, I.W., Guimarães, G.C., Carvalho, A.L., de Camargo, B., Lopes, A., Squire, J.A., Soares, F.A.: Prognostic impact of adenomatous polyposis coli gene expression in osteosarcoma of the extremities. Eur. J. Cancer 46, 3307–3315 (2010)CrossRef Guimarães, A.P.G., Rocha, R.M., da Cunha, I.W., Guimarães, G.C., Carvalho, A.L., de Camargo, B., Lopes, A., Squire, J.A., Soares, F.A.: Prognostic impact of adenomatous polyposis coli gene expression in osteosarcoma of the extremities. Eur. J. Cancer 46, 3307–3315 (2010)CrossRef
23.
Zurück zum Zitat Williamsand, B.O.: K.L. Insogna.: Where Wnts went: the exploding field of Lrp5 and Lrp6 signaling in bone. J. Bone Miner. Res. 24, 171–178 (2009)CrossRef Williamsand, B.O.: K.L. Insogna.: Where Wnts went: the exploding field of Lrp5 and Lrp6 signaling in bone. J. Bone Miner. Res. 24, 171–178 (2009)CrossRef
24.
Zurück zum Zitat Li, Y., Lu, W., He, X., Schwartz, A.L., Bu, G.: LRP6 expression promotes cancer cell proliferation and tumorigenesis by altering β-catenin subcellular distribution. Oncogene 23, 9129–9135 (2004)CrossRef Li, Y., Lu, W., He, X., Schwartz, A.L., Bu, G.: LRP6 expression promotes cancer cell proliferation and tumorigenesis by altering β-catenin subcellular distribution. Oncogene 23, 9129–9135 (2004)CrossRef
Metadaten
Titel
Identification of Osteosarcoma-Related Genes Based on Bioinformatics Methods
verfasst von
Ze-Bing Si
Ji-Gong Wu
Copyright-Jahr
2015
DOI
https://doi.org/10.1007/978-3-319-22186-1_35